Evidence map›Paper›PMID 42888431›Full record

ArticleCell communication and signaling : CCS2026

Dying cells initiate DLL4-Notch signaling to drive tumor repopulation after insufficient thermal ablation of papillary thyroid carcinoma.

Yongchao Yu, Weichao Chen, Zan Jiao, Kang Ning, Taonong Cai, Bu Zou, Honghao Deng, Tong Wu, Zhongyuan Yang, Feng Han and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yongchao Yu *State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
Weichao Chen *State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
Zan Jiao *State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
Kang NingState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
Taonong CaiState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
Bu ZouState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
Honghao DengState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
Tong WuState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
Zhongyuan YangState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
Feng HanState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China. hanfeng@sysucc.org.cn.
Ankui YangState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China. yangak@sysucc.org.cn.
Mingjie JiangState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China. jiangmj1@sysucc.org.cn.

Funding

Fundamental Research Funds for the Central Universities, Sun Yat-sen University 24qnpy279Guangzhou Basic and Applied Basic Research Foundation 2025A04J3600National Natural Science Foundation of China 82573603, 82272649, 82303881, 82403855, 82403078
6 · The paper itself

Abstract

backgroundAlthough lacking high-quality clinical evidence, the use of thermal ablation for papillary thyroid carcinoma (PTC) is increasing. Emerging evidence suggests that thermal ablation may accelerate tumor progression in some patients, but the underlying biological mechanisms remain unclear. This study aims to explore the mechanisms of tumor repopulation following thermal ablation and identify possible intervention strategies. MATERIALS AND

methodsIn vitro and in vivo models were employed to simulate tumor repopulation after thermal ablation and investigate mechanisms. Clinicopathological features of post-ablation surgical specimens were analyzed, and Xenium in situ spatial transcriptomics was conducted. Time-lapse imaging and RNA-seq explored how dying cells influence surviving cells. qPCR, WB, IHC, and flow cytometry validated molecular mechanisms, while enChIP-MS identified upstream regulators.

resultsPost-ablation PTC tissue showed significantly higher proliferative potential. Heat-induced dying cells promote surviving cell repopulation in a contact-dependent manner. Dying cells upregulated DLL4, activating Notch signaling in surviving cells and driving proliferation. Clinical specimens and Xenium in situ spatial transcriptomics revealed elevated Notch activity in tumor cells adjacent to the ablation bed. Inhibition of DLL4-Notch signaling attenuated the dying cell-induced proliferative advantage in vitro and in vivo. enChIP-MS showed HNRNPU enrichment at the DLL4 promoter after heat treatment. Mechanistically, heat treatment increased HNRNPU nuclear enrichment and binding at the DLL4 promoter, facilitating DLL4 transcription.

conclusionHeat-induced dying cells promote tumor repopulation after insufficient thermal ablation in PTC through the DLL4-Notch pathway. With the expanding use of thermal ablation, understanding and mitigating its limitations is essential for clinical advancement.

Indexed as

Ablation TechniquesAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsReceptors, NotchSignal TransductionThyroid Cancer, PapillaryThyroid NeoplasmsAnimalsCell DeathCell Line, TumorCell ProliferationHumansMiceAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsDLL4 protein, humanReceptors, NotchDLL4Dying cellsNotchPapillary thyroid carcinomaThermal ablation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.